Evidence map›Paper›PMID 33942248›Full record

ArticleThe patient2021

Designing HIV Testing and Self-Testing Services for Young People in Nigeria: A Discrete Choice Experiment.

Jason J Ong, Ucheoma Nwaozuru, Chisom Obiezu-Umeh, Collins Airhihenbuwa, Hong Xian, Fern Terris-Prestholt, Titilola Gbajabiamila, Adesola Z Musa, David Oladele, Ifeoma Idigbe and 6 more

Open access · greenAbstract read
In one paragraph

Article in The patient, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 4 pooled it
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 4 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 4 countries.

Jason J OngCentral Clinical School, Monash University, Melbourne, VIC, 3053, Australia. Jason.ong@monash.edu.ORCID 0000-0001-5784-7403
Ucheoma NwaozuruSaint Louis University College for Public Health and Social Justice, St Louis, MO, USA.
Chisom Obiezu-UmehSaint Louis University College for Public Health and Social Justice, St Louis, MO, USA.
Collins AirhihenbuwaGeorgia State University, Atlanta, GA, USA.
Hong XianSaint Louis University College for Public Health and Social Justice, St Louis, MO, USA.
Fern Terris-PrestholtLondon School of Hygiene and Tropical Medicine, London, UK.
Titilola GbajabiamilaThe Nigerian Institute of Medical Research, Lagos, Nigeria.
Adesola Z MusaThe Nigerian Institute of Medical Research, Lagos, Nigeria.
David OladeleThe Nigerian Institute of Medical Research, Lagos, Nigeria.
Ifeoma IdigbeThe Nigerian Institute of Medical Research, Lagos, Nigeria.
Agatha DavidThe Nigerian Institute of Medical Research, Lagos, Nigeria.
Jane OkwuzuThe Nigerian Institute of Medical Research, Lagos, Nigeria.
Tajudeen BamideleThe Nigerian Institute of Medical Research, Lagos, Nigeria.
Juliet IwelunmorSaint Louis University College for Public Health and Social Justice, St Louis, MO, USA.
Joseph D TuckerLondon School of Hygiene and Tropical Medicine, London, UK.
Oliver EzechiThe Nigerian Institute of Medical Research, Lagos, Nigeria.
Nigerian Institute of Medical Research · NGSaint Louis University · USGeorgia State University · USLondon School of Hygiene & Tropical Medicine · GBUniversity of London · GBUniversity of North Carolina at Chapel Hill · US

Funding

ITEST: Innovative Tools to Expand Youth-Friendly HIV Self-TestingUG3HD096929 · NICHD · SAINT LOUIS UNIVERSITY · PI EZECHI, OLIVER CHUKWUJEKWU, IWELUNMOR, JULIET · 2018 to 2019
$2.3M
NICHD NIH HHS UG3 HD096929
6 · The paper itself

Abstract

BACKGROUND AND

objectiveA third of new human immunodeficiency virus (HIV) infections occur among young people and the majority of young people living with HIV are in sub-Saharan Africa. We examined the strength of Nigerian youth preferences related to HIV testing and HIV self-testing (HIVST).

methodsDiscrete choice experiments were conducted among Nigerian youth (age 14-24 years). Participants completed one of two discrete choice experiments: (1) preferred qualities of HIV testing (cost, location of test, type of test, person who conducts the test, and availability of HIV medicine at the testing site) and (2) preferred qualities of HIVST kits (cost, test quality, type of test, extra items, and support if tested positive). A random parameter logit model measured the strength of preferences.

resultsA total of 504 youth participated: mean age 21 years (standard deviation 2 years), 38% male, and 35% had a higher than secondary school education. There was a strong preference overall to test given the scenarios presented, although male individuals were less likely to test for HIV or use HIVST kits. Youth preferred HIV testing services (with attributes in order of importance) that are free, blood-based testing, available in private/public hospitals or home, for HIV medications to be available in the same location as testing, and a doctor conducts the test. Participants preferred HIVST kits (with attributes in order of importance) that are available from community health centers, free, approved by the World Health Organization, include other sexually transmitted infection testing, have the option of an online chat, and oral-based HIVST.

conclusionsThe HIV home testing was equally preferred to testing in a hospital, suggesting a viable market for HIVST if kits account for youth preferences. Male youth were less likely to choose to test for HIV or use HIVST kits, underscoring the need for further efforts to encourage HIV testing among young male individuals.

Indexed as

HIV InfectionsSelf-TestingAdolescentAdultFemaleHIV TestingHumansMaleMass ScreeningNigeriaReagent Kits, DiagnosticYoung AdultReagent Kits, Diagnostic

Identifiers

PMID33942248
PMCPMC8566316
OpenAlexW3158617134

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.